CD19/BAFF-R in vivo CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19/BAFF-R in vivo CAR-T cell therapy, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma [Phase 1]